Neil K Warma
CIK 1437911 · Chief Executive Officer · last filed 2026-05-22
Neil K Warma is a Chief Executive Officer who has filed 26 SEC Form 4 insider transactions across 2 companies since 2008. The most recent filing, for PMN, was dated May 22, 2026. Across all open-market trades the lifetime net is +$24.1K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $64.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$64.0K
2
26
$24.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PMN | Chief Executive Officer | 6,183 | $10.35 | $64.0K | $0 | 5 | 2026-05-22 |
| Acer Therapeutics Inc. (OPXAW) Delisted | President, CEO and Acting CFO | 144,881 | — | — | $24.1K | 21 | 2016-05-18 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-22 | PMN | Grant (A) | — | $0 | EDGAR |
| 2026-02-05 | PMN | Grant (A) | +6,183 | $75.0K | EDGAR |
| 2025-09-24 | PMN | Grant (A) | — | $0 | EDGAR |
| 2024-10-10 | PMN | Grant (A) | — | $0 | EDGAR |
| 2024-01-05 | PMN | Grant (A) | — | $0 | EDGAR |
| 2016-05-18 | Acer Therapeutics Inc. (OPXAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-04-09 | Acer Therapeutics Inc. (OPXAW) Delisted | Exer (M) | +37,247 | $0 | EDGAR |
| 2015-03-04 | Acer Therapeutics Inc. (OPXAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-09-17 | Acer Therapeutics Inc. (OPXAW) Delisted | Buy (P) | +10,000 | $11.1K | EDGAR |
| 2014-03-04 | Acer Therapeutics Inc. (OPXAW) Delisted | Grant (A) | +51,748 | $0 | EDGAR |